Toby Capstick
Leeds Teaching Hospitals NHS Trust
Clinical pharmacyInternal medicineIntensive care medicineBest practicePediatricsConsistency (negotiation)Disease management (health)AsthmaARDSClinical auditCOPDThoraxClinical governanceBetacoronavirusNontuberculous mycobacteriaComorbidityPatient safetyMEDLINEGuidelineInhalerConventionPopulationSteroid useAcute respiratory distressAirways diseaseAtypical mycobacterial infectionCorticosteroid useEmergency reliefPulmonary disease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Non tuberculous mycobacterialGood practiceIn patientHigh mortalityHealth professionalsSevere asthmaCopd patientsFamily medicineClinical trialMedicinePandemicMeta-analysis
6Publications
5H-index
161Citations
Publications 9
Newest
#1Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
#2Nooria F. Azeez (Leeds Teaching Hospitals NHS Trust)
Last. Ian Clifton (Leeds Teaching Hospitals NHS Trust)H-Index: 12
view all 6 authors...
Abstract null null Background null The management of asthma and COPD is largely dependent on patients being able to use their inhaled medication correctly, but poor inhaler technique continues to be a recurring theme in studies and clinical practice. This is associated with poor disease control, increased risk of exacerbations and hospital admissions, and so there is a need to redesign services for patients to optimise their medicines use. null null null Methods null A novel ward-based dedicated...
Source
#2Toby CapstickH-Index: 5
INTRODUCTIONThe 2018 Cape Town Declaration identifies the activities of the tobacco industry as incompatible with the human right to health1. The Global Burden of Disease Study estimates the annual global death toll from smoking to be 8.71 million2. Through the cultivation, production, processing and disposal of its products, the industry creates a substantial burden on the environment, which falls mainly in low and middle-income countries3. Tobacco multinationals stand condemned as a major obst...
Source
#1Chia Siang Kow (International Medical University)H-Index: 12
#2Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
Last. Syed Shahzad Hasan (University of Newcastle)H-Index: 20
view all 3 authors...
Source
#1Chia Siang Kow (International Medical University)H-Index: 12
#2Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
Last. Syed Shahzad Hasan (University of Huddersfield)H-Index: 20
view all 4 authors...
Background A significant knowledge gap exists for the management of critically ill patients with coronavirus disease 2019 (COVID-19). This study aimed to systematically investigate the consistency of recommendations from the available clinical practice guidelines (CPGs) to those of the WHO on the management of critically ill COVID-19 patients. Methods We examined CPGs and UpToDate point-of-care resources on the management of critically ill COVID-19 patients that had been published as of 30 April...
Source
#1Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
#2Nicholas S Hopkinson (NIH: National Institutes of Health)H-Index: 62
The takeover of Vectura, a healthcare company specialising in inhaled medication, by Philip Morris International raises serious ethical concerns. The European Respiratory Society notes that "health professionals will avoid prescribing drugs from any company that enriches the tobacco industry due to the ethical implications". People with chronic obstructive pulmonary disease (COPD) and asthma will also be reluctant to use medications which profit a company that is estimated to kill at least one m...
Source
#1Syed Shahzad Hasan (University of Huddersfield)H-Index: 20
#2Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
Last. Syed Tabish R. Zaidi (University of Leeds)H-Index: 17
view all 7 authors...
Objectives The acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis is one of the main causes of high mortality in COVID-19 patients. We systematically reviewed ARDS-associated mortality and the potential role of systemic corticosteroids in COVID-19 patients. Methods Electronic databases and country-specific reports were searched to identify relevant studies. The mortality data from these studies were pooled for statistical analysis, and subgroup analysis and quality assessm...
Source
#1Syed Shahzad Hasan (University of Huddersfield)H-Index: 20
#2Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
Last. Hamid A. Merchant (University of Huddersfield)H-Index: 18
view all 5 authors...
Abstract The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare professionals regarding the safety of steroid use during the SARS-CoV-2 pandemic. The corticosteroids (inhaled and oral) are commonly prescribed in the management of asthma and COPD patients and any...
Source
#1Charles S. Haworth (Papworth Hospital)H-Index: 34
#2John Banks (Abertawe Bro Morgannwg University Health Board)H-Index: 5
Last. R. Andres FlotoH-Index: 34
view all 16 authors...
The full guideline for the management of non-tuberculous mycobacterial pulmonary disease is published in Thorax . The following is a summary of the recommendations and good practice points. The sections referred to in the summary refer to the full guideline.
Source
#1Monica Fletcher (Warw.: University of Warwick)H-Index: 24
#2Jane Scullion (University of Leicester)H-Index: 8
Last. Toby Capstick (Leeds Teaching Hospitals NHS Trust)H-Index: 5
view all 5 authors...
An official color-code system should be introduced for inhaled medication as UK survey results indicate the importance of the blue inhaler. Monica Fletcher at Education for Health in Warwick and colleagues on behalf of the UK Inhaler Group conducted a survey of 596 healthcare professionals and 2127 patients with airways disease to determine how important colored labelling is on inhaler medication. Traditionally, the short-acting beta 2 ‘reliever’ inhaler is colored blue – an unofficial color-cod...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.